Loading organizations...
Key people at TEKAMA.
Tekama Advisory provides strategic consultancy and advisory services specifically tailored for organizations within the health technology and innovation sector. The firm specializes in guiding clients through complex landscapes, offering expertise in governance, operational frameworks, and strategic planning. They focus on developing bespoke strategies that integrate health innovation with effective public policy and robust business growth initiatives, ensuring purposeful direction and maximized impact for their clients.
The company was established in 2022 by founder Terri Lohnes. Her insight to create Tekama Advisory stemmed from over two decades of extensive leadership experience across public, private, and non-profit sectors, including significant roles in government, medtech, and management consulting. Lohnes identified a clear need for seasoned strategic guidance to help entities effectively navigate and execute within the rapidly evolving health innovation ecosystem.
Tekama Advisory serves a diverse clientele ranging from nascent startups and established organizations to founders, funders, C-suite executives, and policymakers. The firm’s overarching mission is to empower these stakeholders to successfully launch new ventures, secure funding, refine business strategies, and integrate health tech innovations into practical application. They aim to be the essential strategic partner driving health innovation to successful execution.
Key people at TEKAMA.
TEKAMA — High-level, investor-grade profile.
High-Level Overview
TEKAMA appears to be a small strategic advisory firm (branded as “Tekama” or “Tekama Advisory”) that provides executive- and board-level advisory services to life‑sciences and technology companies, rather than a traditional investment firm or product startup. Tekama positions itself around C‑Suite and board strategy, commercialization and scaling support for growth‑stage companies in regulated and technical industries[8]. Tekama’s public descriptions emphasize strategy execution, go‑to‑market and corporate governance support rather than direct investing or a product offering[8].
Origin Story
Public records and directory listings show at least one corporate entity named TEKAMA LIMITED incorporated in Cyprus (company registry entry) but provide no detailed public founding narrative or founder biographies in the sources found[3]. Tekama Advisory’s member listing with Life Sciences Ontario indicates the firm is established enough to participate in regional industry networks and to offer executive advisory services to life‑sciences clients[8]. There is no clear founding year, named founding partners, or detailed early‑traction milestones available in the searchable public sources returned.
Core Differentiators
Role in the Broader Tech / Life‑Sciences Landscape
Tekama operates at the intersection of board governance, commercialization strategy and executive execution for growth‑stage life‑sciences and technical companies, a space that matters because regulatory complexity and capital constraints make experienced C‑Suite counsel valuable for scaling and fundraising[8]. The trend toward fractional executives and boutique advisory firms has grown as startups and mid‑market companies seek senior experience without the cost of full‑time hires; Tekama’s positioning fits that market demand[8]. Because publicly available information is limited, it’s unclear how large an influence Tekama exerts beyond direct client engagements and local industry networks such as Life Sciences Ontario[8].
Quick Take & Future Outlook
Based on the available sources, Tekama is best understood as a boutique strategic advisory practice serving life‑sciences/tech clients rather than as an investment firm or product company[8][3]. Short‑term growth likely depends on deepening client relationships within life sciences and expanding presence in regional industry networks; longer‑term influence would require publishing case studies, naming partner principals, or disclosing marquee client engagements to build public track record. If Tekama chooses to scale, natural next steps would include clearer public leadership bios, thought leadership content, and documented case studies to amplify credibility and win larger mandates.
Caveat and next steps
Public information about “Tekama” is sparse and fragmented across a membership listing and a corporate registry entry; I could not find a detailed firm website, press coverage, or founder biographies in the sources returned[8][3]. If you want a deeper profile I can:
